News
Janux’s pipeline expansion into autoimmune disease, new immune-oncology product candidates, and over 6-year cash runway ...
Researchers at Lawrence Livermore National Laboratory (LLNL) have reached a milestone in combining AI with fusion target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback